MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window

Neurology. 2006 Apr 11;66(7):1132. doi: 10.1212/01.wnl.0000220161.34879.c1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Brain Ischemia / diagnosis
  • Brain Ischemia / drug therapy*
  • Drug Administration Schedule
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Abciximab